ARTICLE | Management Tracks
Peter Bains named group CEO at Biocon
Plus: CEO changes at Lonza and Black Diamond, and updates from ImmunoGen, BenevolentAI and Nilogen
September 18, 2023 11:50 PM UTC
India-based Biocon Ltd. (NSE:BIOCON; BSE:532523) named Peter Bains as group CEO. Bains, a 23-year veteran of GSK plc (LSE:GSK; NYSE:GSK), was CEO of Biocon’s Syngene International Ltd. (NSE:SYNGENE; BSE:SYNGENE) from 2010 until 2016 and CEO of Sosei Group Corp. (Tokyo:4565) from 2011 until 2018. Bains has served as CBO of MiNA Therapeutics Ltd. since 2020.
Pierre-Alain Ruffieux will step down as CEO of Lonza Group Ltd. (SIX:LONN) by Sept. 30. Chairman Albert Baehny will take on the responsibilities of CEO until a successor is named...